Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Natera, Inc. director and co-founder Sheena Jonathan reported pre-planned sales of company stock by family trusts. On June 17, 2026, Caraluna 1 and Caraluna 2 Trusts together sold 1,500 shares of Natera common stock in a series of open-market transactions under a Rule 10b5-1 trading plan adopted on June 7, 2024. The sales were executed at weighted average prices around the low- to mid-$220 per share range, based on multiple trades within narrow price bands. After these transactions, Jonathan continues to report 249,352 shares held directly, while Caraluna 1 Trust holds 19,276 shares and Caraluna 2 Trust holds 19,265 shares. The filing notes the trusts hold shares for their beneficiaries and that Jonathan disclaims beneficial ownership of the trust-held securities.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 1,500 shares ($329,810)
Net Sell
10 txns
Insider
Sheena Jonathan
Role
Director
Sold
1,500 shs ($330K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 256 | $218.1371 | $56K |
| Sale | Common Stock | 128 | $219.2576 | $28K |
| Sale | Common Stock | 122 | $220.9254 | $27K |
| Sale | Common Stock | 244 | $221.4641 | $54K |
| Sale | Common Stock | 267 | $218.1752 | $58K |
| Sale | Common Stock | 96 | $219.1321 | $21K |
| Sale | Common Stock | 71 | $220.4632 | $16K |
| Sale | Common Stock | 301 | $221.3855 | $67K |
| Sale | Common Stock | 15 | $222.144 | $3K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 19,276 shares (Indirect, By Caraluna 1 Trust);
Common Stock — 249,352 shares (Direct)
Footnotes (1)
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.74 to $218.56 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.88 to $219.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.26 to $221.21 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.26 to $222.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.73 to $218.68 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.75 to $219.37 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.94 to $220.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.10 to $221.93 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222,03 to $222.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 1,500 shares
Example sale price: $222.1440 per share
Direct holdings: 249,352 shares
+5 more
8 metrics
Shares sold
1,500 shares
Total common shares sold on June 17, 2026
Example sale price
$222.1440 per share
Weighted average price for one reported sale block
Direct holdings
249,352 shares
Shares reported as held directly after transactions
Caraluna 1 Trust holdings
19,276 shares
Common stock held by Caraluna 1 Trust after sales
Caraluna 2 Trust holdings
19,265 shares
Common stock held by Caraluna 2 Trust after sales
Net insider share change
-1,500 shares
Net effect of reported buy/sell activity (net-sell)
Number of sale transactions
9 transactions
Open-market sale entries coded “S” on Form 4
10b5-1 plan adoption date
June 7, 2024
Date the pre-arranged trading plan was adopted
Key Terms
Rule 10b5-1 trading plan, weighted average price, beneficial ownership, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership over such securities."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
"transaction_type: "non-derivative" for the common stock sales"
FAQ
What insider activity did Natera (NTRA) report for Sheena Jonathan?
Natera reported that trusts associated with director and co-founder Sheena Jonathan sold 1,500 shares of common stock. The transactions were open-market sales executed on June 17, 2026, and reported on a Form 4 insider trading filing with the SEC.
What kind of transaction code appears in the Natera (NTRA) Form 4?
The sales are coded with transaction code “S,” which indicates open-market or private sales of non-derivative common stock. There are no option exercises or derivative transactions reported in this Form 4, only common stock sales and a holding entry.